Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
February 2, 2024
CNBC
Innoviva Inc (NASDAQ: INVA ) has agreed to acquire La Jolla Pharmaceutical Company (NASDAQ: LJPC ) for $5.95 per share, representing a premium of approximately 70% to the 30-day volume-weighted average price.
Innoviva will also pay an incremental $0.28 per share for additional cash proceeds ... Full story available on Benzinga.com
SweepCast
Simplest Unusual Options Activity Platform for traders. SweepCast can be used for swing or day traders who are looking to get insights on where Smart money is flowing, sign up today.